{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:15:52Z","timestamp":1785161752428,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,1,5]],"date-time":"2014-01-05T00:00:00Z","timestamp":1388880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s11033-013-2996-2","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T12:43:46Z","timestamp":1388839426000},"page":"1511-1518","source":"Crossref","is-referenced-by-count":23,"title":["VPA inhibits renal cancer cell migration by targeting HDAC2 and down-regulating HIF-1\u03b1"],"prefix":"10.1007","volume":"41","author":[{"given":"Feng-qiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,5]]},"reference":[{"issue":"4","key":"2996_CR1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.urology.2010.10.014","volume":"77","author":"C Ji","year":"2011","unstructured":"Ji C, Li X, Zhang S et al (2011) Laparoscopic radiofrequency ablation of renal tumors: 32-month mean follow-up results of 106 patients. Urology 77(4):798\u2013802","journal-title":"Urology"},{"issue":"11","key":"2996_CR2","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1111\/j.1464-410X.2012.11518.x","volume":"110","author":"R Iacovelli","year":"2012","unstructured":"Iacovelli R, Lanoy E, Albiges L, Escudier B (2012) Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma. BJU Int 110(11):1747\u20131753","journal-title":"BJU Int"},{"issue":"1","key":"2996_CR3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.3029","volume":"19","author":"S Vanharanta","year":"2013","unstructured":"Vanharanta S, Shu W, Brenet F et al (2013) Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat Med 19(1):50\u201356","journal-title":"Nat Med"},{"issue":"11","key":"2996_CR4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.4155\/fmc.12.80","volume":"4","author":"G Giannini","year":"2012","unstructured":"Giannini G, Cabri W, Fattorusso C, Rodriquez M (2012) Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives. Future Med Chem 4(11):1439\u20131460","journal-title":"Future Med Chem"},{"issue":"6","key":"2996_CR5","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bcp.2012.06.014","volume":"84","author":"S Dallavalle","year":"2012","unstructured":"Dallavalle S, Pisano C, Zunino F et al (2012) Development and therapeutic impact of HDAC6-selective inhibitors. Biochem Pharmacol 84(6):756\u2013765","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"2996_CR6","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/13543784.2012.694425","volume":"21","author":"S Berendsen","year":"2012","unstructured":"Berendsen S, Broekman M, Seute T et al (2012) Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results. Expert Opin Investig Drugs 21(9):1391\u20131415","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"2996_CR7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12094-010-0527-3","volume":"12","author":"M Cotto","year":"2010","unstructured":"Cotto M, Cabanillas F, Tirado M et al (2010) Epigenetic therapy of lymphoma using histone deacetylase inhibitors. Clin Transl Oncol 12(6):401\u2013409","journal-title":"Clin Transl Oncol"},{"key":"2996_CR8","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1038\/cddis.2011.48","volume":"2","author":"A Sermeus","year":"2011","unstructured":"Sermeus A, Michiels C (2011) Reciprocal influence of the p53 and the hypoxic pathways. Cell Death Dis 2:e164","journal-title":"Cell Death Dis"},{"issue":"4","key":"2996_CR9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1081\/CLT-100105159","volume":"39","author":"MM Iqbal","year":"2001","unstructured":"Iqbal MM, Sohhan T, Mahmud SZ (2001) The effects of lithium, valproic acid, and carbamazepine during pregnancy and lactation. J Toxicol Clin Toxicol 39(4):381\u2013392","journal-title":"J Toxicol Clin Toxicol"},{"issue":"1","key":"2996_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.gene.2011.12.058","volume":"498","author":"N Chen","year":"2012","unstructured":"Chen N, Chen LP, Zhang J et al (2012) Molecular characterization and expression analysis of three hypoxia-inducible factor alpha subunits, HIF-1\u03b1\/2\u03b1\/3\u03b1 of the hypoxia-sensitive freshwater species, Chinese sucker. Gene 498(1):81\u201390","journal-title":"Gene"},{"issue":"40","key":"2996_CR11","doi-asserted-by":"crossref","first-page":"E2707","DOI":"10.1073\/pnas.1214019109","volume":"109","author":"L Schito","year":"2012","unstructured":"Schito L, Rey S, Tafani M et al (2012) Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc Natl Acad Sci USA 109(40):E2707\u2013E2716","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2996_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/epi.10.20","volume":"2","author":"VM Richon","year":"2010","unstructured":"Richon VM (2010) Targeting histone deacetylases: development of vorinostat for the treatment of cancer. Epigenomics 2(3):457\u2013465","journal-title":"Epigenomics"},{"issue":"12","key":"2996_CR13","doi-asserted-by":"crossref","first-page":"e52095","DOI":"10.1371\/journal.pone.0052095","volume":"7","author":"G Wang","year":"2012","unstructured":"Wang G, He J, Zhao J et al (2012) Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer. PLoS One 7(12):e52095","journal-title":"PLoS One"},{"issue":"5","key":"2996_CR14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/leu.2011.315","volume":"26","author":"E McCormack","year":"2012","unstructured":"McCormack E, Haaland I, Ven\u00e5s G et al (2012) Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia. Leukemia 26(5):910\u2013917","journal-title":"Leukemia"},{"key":"2996_CR15","doi-asserted-by":"crossref","unstructured":"Mamlouk S, Wielockx B (2012) Hypoxia-inducible factors as key regulators of tumor inflammation. Int J Cancer. doi: 10.1002\/ijc.27901","DOI":"10.1002\/ijc.27901"},{"issue":"5","key":"2996_CR16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.annpat.2008.06.031","volume":"28","author":"J Edeline","year":"2008","unstructured":"Edeline J, Rioux-Leclercq N (2008) Renal cell carcinoma and prognostic factors. Ann Pathol 28(5):374\u2013380","journal-title":"Ann Pathol"},{"issue":"6","key":"2996_CR17","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1586\/era.10.62","volume":"10","author":"BN Singh","year":"2010","unstructured":"Singh BN, Zhang G, Hwa YL et al (2010) Nonhistone protein acetylation as cancer therapy targets. Expert Rev Anticancer Ther 10(6):935\u2013954","journal-title":"Expert Rev Anticancer Ther"},{"key":"2996_CR18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-1-61779-867-2_23","volume":"889","author":"E Menegola","year":"2012","unstructured":"Menegola E, Cappelletti G, Di Renzo F (2012) Epigenetic approaches and methods in developmental toxicology: role of HDAC inhibition in teratogenic events. Methods Mol Biol 889:373\u2013383","journal-title":"Methods Mol Biol"},{"issue":"1","key":"2996_CR19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/nar\/gks959","volume":"41","author":"S Seuter","year":"2013","unstructured":"Seuter S, Heikkinen S, Carlberg C (2013) Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1\u03b1,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression. Nucleic Acids Res 41(1):110\u2013124","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2996_CR20","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1158\/1078-0432.CCR-07-4306","volume":"14","author":"HM Verheul","year":"2008","unstructured":"Verheul HM, Salumbides B, Van Erp K et al (2008) Combination strategy targeting the hypoxia inducible factor-1 alpha with mammalian target of rapamycin and histone deacetylase inhibitors. Clin Cancer Res 14(11):3589\u20133597","journal-title":"Clin Cancer Res"},{"issue":"44","key":"2996_CR21","doi-asserted-by":"crossref","first-page":"38095","DOI":"10.1074\/jbc.M111.257055","volume":"286","author":"H Geng","year":"2011","unstructured":"Geng H, Harvey CT, Pittsenbarger J et al (2011) HDAC4 protein regulates HIF1\u03b1 protein lysine acetylation and cancer cell response to hypoxia. J Biol Chem 286(44):38095\u201338102","journal-title":"J Biol Chem"},{"issue":"2","key":"2996_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.taap.2012.11.014","volume":"266","author":"Y Xu","year":"2013","unstructured":"Xu Y, Li Y, Li H et al (2013) The accumulations of HIF-1\u03b1 and HIF-2\u03b1 by JNK and ERK are involved in biphasic effects induced by different levels of arsenite in human bronchial epithelial cells. Toxicol Appl Pharmacol 266(2):187\u2013197","journal-title":"Toxicol Appl Pharmacol"},{"issue":"17","key":"2996_CR23","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.1158\/0008-5472.CAN-05-4598","volume":"66","author":"DZ Qian","year":"2006","unstructured":"Qian DZ, Kachhap SK, Collis SJ et al (2006) Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha. Cancer Res 66(17):8814\u20138821","journal-title":"Cancer Res"},{"issue":"8","key":"2996_CR24","first-page":"3161","volume":"32","author":"MJ Kim","year":"2012","unstructured":"Kim MJ, Kim DE, Jeong IG et al (2012) HDAC inhibitors synergize antiproliferative effect of sorafenib in renal cell carcinoma cells. Anticancer Res 32(8):3161\u20133168","journal-title":"Anticancer Res"},{"issue":"3","key":"2996_CR25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/145749691210100304","volume":"101","author":"SJ Oddsson","year":"2012","unstructured":"Oddsson SJ, Hardarson S, Petursdottir V et al (2012) Synchronous pulmonary metastases from renal cell carcinoma\u2014a whole nation study on prevalence and potential resectability. Scand J Surg 101(3):160\u2013165","journal-title":"Scand J Surg"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2996-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-013-2996-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-013-2996-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T03:16:27Z","timestamp":1559358987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-013-2996-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,5]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["2996"],"URL":"https:\/\/doi.org\/10.1007\/s11033-013-2996-2","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,5]]}}}